Barclays’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $445K | Sell |
30,000
-156,140
| -84% | -$2.28M | ﹤0.01% | 3255 |
|
|
2025
Q4 | $2.97M | Buy |
186,140
+14,540
| +8% | +$206K | ﹤0.01% | 2646 |
|
|
2025
Q3 | $1.9M | Sell |
171,600
-78,720
| -31% | -$860K | ﹤0.01% | 2936 |
|
|
2025
Q2 | $2.12M | Buy |
250,320
+71,787
| +40% | +$575K | ﹤0.01% | 2799 |
|
|
2025
Q1 | $1.44M | Sell |
178,533
-65,415
| -27% | -$530K | ﹤0.01% | 2888 |
|
|
2024
Q4 | $2.19M | Buy |
243,948
+24,617
| +11% | +$201K | ﹤0.01% | 2813 |
|
|
2024
Q3 | $1.61M | Buy |
219,331
+143,072
| +188% | +$887K | ﹤0.01% | 3033 |
|
|
2024
Q2 | $435K | Sell |
76,259
-96,465
| -56% | -$508K | ﹤0.01% | 3122 |
|
|
2024
Q1 | $865K | Sell |
172,724
-45,723
| -21% | -$310K | ﹤0.01% | 3233 |
|
|
2023
Q4 | $1.96M | Buy |
218,447
+90,719
| +71% | +$747K | ﹤0.01% | 2931 |
|
|
2023
Q3 | $992K | Buy |
127,728
+77,594
| +155% | +$759K | ﹤0.01% | 2341 |
|
|
2023
Q2 | $485K | Sell |
50,134
-17,819
| -26% | -$185K | ﹤0.01% | 2772 |
|
|
2023
Q1 | $745K | Buy |
67,953
+3,230
| +5% | +$28.5K | ﹤0.01% | 2962 |
|
|
2022
Q4 | $280K | Sell |
64,723
-592,079
| -90% | -$3.44M | ﹤0.01% | 3670 |
|
|
2022
Q3 | $4.94M | Sell |
656,802
-384,252
| -37% | -$3.33M | 0.01% | 1174 |
|
|
2022
Q2 | $10.5M | Buy |
1,041,054
+597,256
| +135% | +$6.68M | 0.01% | 1002 |
|
|
2022
Q1 | $5.49M | Sell |
443,798
-90,409
| -17% | -$1.4M | ﹤0.01% | 1200 |
|
|
2021
Q4 | $12.2M | Sell |
534,207
-60,599
| -10% | -$1.44M | ﹤0.01% | 1165 |
|
|
2021
Q3 | $13.2M | Buy |
594,806
+403,950
| +212% | +$6.41M | 0.01% | 1049 |
|
|
2021
Q2 | $2.47M | Sell |
190,856
-224,404
| -54% | -$2.86M | ﹤0.01% | 2057 |
|
|
2021
Q1 | $5.39M | Buy |
415,260
+256,236
| +161% | +$3.72M | ﹤0.01% | 1457 |
|
|
2020
Q4 | $2.2M | Sell |
159,024
-63,000
| -28% | -$917K | ﹤0.01% | 2160 |
|
|
2020
Q3 | $3.27M | Buy |
222,024
+144,338
| +186% | +$2.09M | ﹤0.01% | 1703 |
|
|
2020
Q2 | $1.26M | Hold |
77,686
| – | – | ﹤0.01% | 2543 |
|
|
2020
Q1 | $1.13M | Sell |
77,686
-26,689
| -26% | -$471K | ﹤0.01% | 2827 |
|
|
2019
Q4 | $2.12M | Buy |
104,375
+34,115
| +49% | +$314K | ﹤0.01% | 2938 |
|
|
2019
Q3 | $376K | Buy |
70,260
+69,593
| +10,434% | +$421K | ﹤0.01% | 4471 |
|
|
2019
Q2 | $4K | Sell |
667
-323
| -33% | -$2.06K | ﹤0.01% | 6710 |
|
|
2019
Q1 | $6K | Buy |
+990
| New | +$6.57K | ﹤0.01% | 6664 |
|
|
2018
Q3 | – | Sell |
-30
| Closed | -$168 | – | 7101 |
|
|
2018
Q2 | $0 | Sell |
30
-990
| -97% | -$5.52K | ﹤0.01% | 6956 |
|
|
2018
Q1 | $5K | Buy |
+1,020
| New | +$5.46K | ﹤0.01% | 6779 |
|
|
2017
Q4 | – | Sell |
-19,100
| Closed | -$120K | – | 6913 |
|
|
2017
Q3 | $120K | Buy |
19,100
+16,300
| +582% | +$103K | ﹤0.01% | 4797 |
|
|
2017
Q2 | $17K | Buy |
+2,800
| New | +$18.9K | ﹤0.01% | 5857 |
|
Other funds holding AUPH
TCM
NMC
